Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Antiphospholipid Syndrome Clinical Trials
Antiphospholipid Syndrome clinical trials are recruiting across 119 cities. Here are the cities with the most active studies:
Antiphospholipid Syndrome Trial Phases
86 research organizations are sponsoring antiphospholipid syndrome trials.
About Antiphospholipid Syndrome
Antiphospholipid syndrome is an autoimmune disorder that increases the risk of blood clots in arteries and veins, and pregnancy complications. It occurs when the immune system makes antibodies that attack phospholipids. Treatment primarily involves anticoagulant medications.
Clinical trials are advancing new treatments for antiphospholipid syndrome. Currently, 100 studies are recruiting a combined 19,637 participants across the United States. Research is being conducted by 86 organizations including Duke University, Massachusetts General Hospital, TG Therapeutics, Inc. and 83 others.
2026 Antiphospholipid Syndrome Research Landscape
As of July 2026, the antiphospholipid syndrome clinical trial landscape includes 100 actively recruiting studies across 119 cities in the United States. These studies are collectively seeking 19,637 participants, with an average enrollment target of 196 per study.
The research spans multiple phases of development: 54 studies are in PHASE1, 17 studies are in PHASE2, 13 studies are in NA, 5 studies are in PHASE3, 3 studies are in PHASE4, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some antiphospholipid syndrome treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 86 different organizations, including Duke University, Massachusetts General Hospital, TG Therapeutics, Inc., Regeneron Pharmaceuticals, Hospital for Special Surgery, New York, and 81 others. The large number of sponsors reflects significant research interest and investment in antiphospholipid syndrome treatment advancement.
Geographically, antiphospholipid syndrome trials are most concentrated in New York, New York (21 trials); Boston, Massachusetts (18 trials); Atlanta, Georgia (16 trials); Houston, Texas (14 trials); Duarte, California (12 trials) and 7 other cities.
Featured Antiphospholipid Syndrome Studies
Highlighted recruiting studies for antiphospholipid syndrome, selected by enrollment size and research scope.
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
Antiphospholipid antibody syndrome (APS) is characterized by the presence of antiphospholipid antibodies, which are proteins in the blood that interfere with the body's ability to perform normal blood clotting. Clinical problems associated with antiphospholipid antibodies include an increased risk for the formation of blood clots in the lungs or deep veins of the legs, stroke, heart attack, and re...
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
This research study is evaluating whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of life, symptoms, mood, coping, and end of life outcomes in patients with acute myeloid leukemia (AML).
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting
Frequently Asked Questions About Antiphospholipid Syndrome Clinical Trials
Are there antiphospholipid syndrome clinical trials near me?
Yes, there are 100 antiphospholipid syndrome clinical trials currently recruiting across 119+ cities in the United States, including New York, New York; Boston, Massachusetts; Atlanta, Georgia. Browse the studies above to find one at a location convenient for you.
How do I join a antiphospholipid syndrome clinical trial?
To join a antiphospholipid syndrome clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are antiphospholipid syndrome clinical trials free?
Yes, participation in antiphospholipid syndrome clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of antiphospholipid syndrome treatments are being studied?
Current antiphospholipid syndrome clinical trials are testing a range of approaches across PHASE1 (54 studies), PHASE2 (17 studies), NA (13 studies), PHASE3 (5 studies), PHASE4 (3 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 86 research organizations.
Is it safe to participate in antiphospholipid syndrome clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov